High-dose rifampicin to treat tuberculosis infection: potential and pitfalls

被引：0
|
作者：
Ryckman, Theresa S. [1 ]
Salazar-Austin, Nicole [2 ]
机构：
[1] Johns Hopkins Sch Med, Div Infect Dis, Baltimore, MD 21230 USA
[2] Johns Hopkins Sch Med, Dept Pediat, Baltimore, MD 21230 USA
来源：
LANCET RESPIRATORY MEDICINE | 2024年 / 12卷 / 06期
关键词：
D O I：
10.1016/S2213-2600(24)00107-3
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：420 / 421
页数：2
相关论文
共 50 条
  • [31] POTENTIALLY SERIOUS SIDE EFFECTS OF HIGH-DOSE TWICE-WEEKLY RIFAMPICIN
    POOLE, G
    STRADLING, P
    WORLLEDGE, S
    BMJ-BRITISH MEDICAL JOURNAL, 1971, 3 (5770): : 343 - +
  • [32] A study on polymorphic forms of rifampicin for inhaled high dose delivery in tuberculosis treatment
    Khadka, Prakash
    Hill, Philip C.
    Zhang, Boya
    Katare, Rajesh
    Dummer, Jack
    Das, Shyamal C.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2020, 587
  • [33] Autophagy promotes efficient T cell responses to restrict high-dose Mycobacterium tuberculosis infection in mice
    Feng, Siwei
    McNehlan, Michael E.
    Kinsella, Rachel L.
    Chowdhury, Chanchal Sur
    Chavez, Sthefany M.
    Naik, Sumanta K.
    McKee, Samuel R.
    Van Winkle, Jacob A.
    Dubey, Neha
    Samuels, Amanda
    Swain, Amanda
    Cui, Xiaoyan
    Hendrix, Skyler V.
    Woodson, Reilly
    Kreamalmeyer, Darren
    Smirnov, Asya
    Artyomov, Maxim N.
    Virgin, Herbert W.
    Wang, Ya-Ting
    Stallings, Christina L.
    NATURE MICROBIOLOGY, 2024, 9 (03) : 582 - 583
  • [34] PHARMACOLOGICALLY-GUIDED DOSE ADJUSTMENT OF BUSULFAN IN HIGH-DOSE CHEMOTHERAPY REGIMENS - RATIONALE AND PITFALLS
    VASSAL, G
    ANTICANCER RESEARCH, 1994, 14 (6A) : 2363 - 2370
  • [35] DOUBLE HIGH-DOSE CHEMOTHERAPY BY THIOTEPA TO TREAT POOR PROGNOSIS OSTEOSARCOMA
    Deparis, M.
    Gaspar, N.
    Brugieres, L.
    Minckes, O.
    Dufour, C.
    Valteau-Couanet, D.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 25 - 25
  • [36] The Rise and Fall of High-Dose Biotin to Treat Progressive Multiple Sclerosis
    Goldschmidt, Carolyn H.
    Cohen, Jeffrey A.
    NEUROTHERAPEUTICS, 2020, 17 (03) : 968 - 970
  • [37] The Rise and Fall of High-Dose Biotin to Treat Progressive Multiple Sclerosis
    Carolyn H. Goldschmidt
    Jeffrey A. Cohen
    Neurotherapeutics, 2020, 17 : 968 - 970
  • [38] FAILURE TO STIMULATE ANTIBODIES IN MAN AFTER 7 DAYS HIGH-DOSE TREATMENT WITH RIFAMPICIN
    BRUMFITT, W
    HAMILTONMILLER, JMT
    WOOD, A
    LANCET, 1981, 2 (8251): : 865 - 865
  • [39] HIGH-DOSE INHALED RIFAMPICIN POWDER FORMULATIONS: PREPARATION, IN VITRO CHARACTERIZATION AND IN VIVO EVALUATION
    Khadka, Prakash
    Sinha, Shubhra
    Tucker, Ian G.
    Dummer, Jack
    Hill, Philip C.
    Katare, Rajesh
    Das, Shyamal C.
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2022, 35 (02) : A7 - A7
  • [40] Pharmacokinetics and safety of high-dose rifampicin in children with TB: the Opti-Rif trial
    Garcia-Prats, Anthony J.
    Svensson, Elin M.
    Winckler, Jana
    Draper, Heather R.
    Fairlie, Lee
    van der Laan, Louvina E.
    Masenya, Masebole
    Schaaf, H. Simon
    Wiesner, Lubbe
    Norman, Jennifer
    Aarnoutse, Rob E.
    Karlsson, Mats O.
    Denti, Paolo
    Hesseling, Anneke C.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2021, 76 (12) : 3237 - 3246
12345